Sickle Cell Disease Regional Care Excellence (SoRCE) Program
Cooperative agreements for hospitals, clinics, and health centers to serve as Regional Coordinating Hubs that expand access to sickle cell disease care, improve care quality, and track patient quality-of-life indicators through regional partnerships and CQI activities.
⚑ Eligibility is limited to hospitals, clinics, and health centers; a public state university cannot apply directly unless it fits one of those categories. · Regional competition: one award recipient per region (7 total). · Program emphasizes service delivery/care coordination and continuous quality improvement, not research. · Cooperative agreement with active federal involvement likely.
Unit fits — one characterization, each unit's own rules
| IPPRA | 15 none | university cannot apply directly (ineligible) |
| Tom Love Innovation Hub | 15 none | deep-tech content; no commercialization signal |
| Physical Sciences & Engineering (demo) | 15 none | university cannot apply directly (ineligible) |
Description
Sickle Cell Disease Regional Care Excellence Program (SoRCE) is to improve the health of people with sickle cell disease (SCD) by expanding access to care, improving the quality of care, and tracking quality of life indicators. There are approximately 100,000 people in the United States with SCD. Treatment starting in early childhood can prevent or reduce complications such as severe pain episodes, silent strokes, and premature death. Despite universal identification at birth, fewer than half of children with SCD receive needed treatment. As these children become adolescents and transition to adulthood many are not appropriately identified as candidates for disease-modifying therapies, in part because their doctors are still learning how to use the latest treatments. The program is made up of seven regions with one award recipient per region serving as a Regional Coordinating Hub (RCH). Each award recipient will work with clinical and community-based partners in their region and engage in continuous quality improvement (CQI) initiatives to improve access and quality of care.
Eligibility
Hospitals or clinicsHealth centers.
Apply
View on Grants.gov → CONTACT: Health Resources and Services Administration <scdprograms@hrsa.gov>
Proposal brief SEE AN EXAMPLE →
A one-page internal memo: fit assessment, submission requirements, document scaffold, and next steps dated back from the deadline — tailored to your project idea if you add one.
Proposal shell · HHS services agencies (SAMHSA / HRSA / CDC / ACF) conventions SEE AN HHS EXAMPLE →
Funder-faithful document skeletons — HHS services agencies (SAMHSA / HRSA / CDC / ACF)'s document set with section headings, page limits, reviewer guidance, and writing prompts; add a project idea to get [DRAFT] starter bullets. Download as .md for Word or Overleaf.
Legacy IPPRA LLM assessment (v2.0, for comparison)
18/100 · gpt-5.4-mini · 2026-07-06
This is a health-services cooperative agreement focused on expanding clinical access, quality improvement, and regional coordination for sickle cell disease. While there is a community and quality-of-life component, it is primarily a care-delivery program rather than a research, survey, or policy study opportunity, and the stated eligibility appears limited to hospitals/clinics/health centers rather than a public research university.
Legacy scoring history
| 2026-07-06 | 18 | gpt-5.4-mini | This is a health-services cooperative agreement focused on expanding clinical access, quality improvement, and regional coordination for sickle cell disease. While there is a community and quality-of-life component, it is primarily a care-delivery program rather than a research, survey, or policy study opportunity, and the stated eligibility appears limited to hospitals/clinics/health centers rather than a public research university. |
| 2026-07-06 | 18 | gpt-5.4-mini | This is a health-services and quality-improvement cooperative agreement focused on sickle cell disease care access, clinical coordination, and quality-of-life tracking. While there is a community-engagement and care-improvement component, the opportunity is restricted to hospitals, clinics, and health centers, so a public research university like OU/IPPRA would not be a direct eligible applicant and could only play a limited partner role. |